HEMOHemogenyx Pharmaceuticals Plc
594.00GBp-6.60%Mkt Cap: 43.90M $P/E:

Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer in the United Kingdom and the United States. The company'…

Key Statistics

Company
Market Cap43.90M $
Enterprise Value42.16M $
Revenue (TTM)
Gross Profit-1.01M $
Net Income (TTM)-10.61M $
Revenue/Share
Last Price594.00 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees16
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-5.72
EV/Revenue
P/S
P/B32.26
EPS (TTM)-1.71
EPS (Forward)
52W Range
156.0027% of range1800.00
52W High1800.00 GBp
52W Low156.00 GBp
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-816.50%
ROA-233.73%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-3.75M $
CapEx (TTM)4.26K $
FCF Margin
FCF Yield-8.24%
Net Debt454.15K $
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity1.68
Current Ratio1.38
Quick Ratio1.09
Book Value/Sh0.1980 GBp
Cash/Share0.2630 GBp
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBp
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:400
Split DateDec 13, 2024
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.6.80M
Float4.65M
Insiders29.43%
Institutions0.41%
Technical
SMA 50726.21 (-18.2%)
SMA 200775.17 (-23.4%)
Beta1.50
S&P 52W Chg18.16%
Avg Vol (30d)9.88K
Avg Vol (10d)8.91K
Technical Indicators
RSI (14)43.1
MACD-30.6093
MACD Signal-31.8104
MACD Hist.+1.2010
BB Upper743.48 GBp
BB Middle655.70 GBp
BB Lower567.92 GBp
BB Width26.77%
ATR (14)62.82 GBp
Vol Ratio (20d)1.27x